Cargando…

Guanylate-Binding Protein 1 as a Potential Predictor of Immunotherapy: A Pan-Cancer Analysis

Background: Mainstream application of cancer immunotherapy is hampered by the low response rate of most cancer patients. A novel immunotherapeutic target or a biomarker predicting response to immunotherapy needs to be developed. Guanylate-binding protein 1 (GBP1) is an interferon (IFN)-inducible gua...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Yaqi, Wu, Jie, Li, Lan, Zhang, Huibo, Zhang, Haohan, Li, Jing, Zhong, Hao, Lei, Tianyu, Jin, Yan, Xu, Bin, Song, Qibin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8867058/ https://www.ncbi.nlm.nih.gov/pubmed/35222540 http://dx.doi.org/10.3389/fgene.2022.820135

Ejemplares similares

Oncolytic Adenovirus: Prospects for Cancer Immunotherapy
por: Zhao, Yaqi, et al.
Publicado: (2021)

Critical role of guanylate binding protein 5 in tumor immune microenvironment and predictive value of immunotherapy response
por: Li, Xiang, et al.
Publicado: (2022)

Pan-cancer analyses confirmed the cuproptosis-related gene FDX1 as an immunotherapy predictor and prognostic biomarker
por: Zhang, Chi, et al.
Publicado: (2022)

The Prognostic and Immunological Value of Guanylate-Binding Proteins in Lower-Grade Glioma: Potential Markers or Not?
por: Liu, Zhuang, et al.
Publicado: (2021)

BACH1: A Potential Predictor of Survival in Early-Stage Lung Adenocarcinoma
por: Zhou, Jin, et al.
Publicado: (2022)

Roles of HMGBs in Prognosis and Immunotherapy: A Pan-Cancer Analysis
por: Lin, Tong, et al.
Publicado: (2021)

Postoperative Radiotherapy for Patients With Resectable Stage III-N2 Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
por: Lei, Tianyu, et al.
Publicado: (2021)

Differential expression of HAVCR2 gene in pan-cancer: A potential biomarker for survival and immunotherapy
por: Li, Hetong, et al.
Publicado: (2022)

An integrated pan-cancer analysis of PSAT1: A potential biomarker for survival and immunotherapy
por: Feng, Mingtao, et al.
Publicado: (2022)

A pan-cancer analysis reveals the genetic alterations and immunotherapy of Piezo2 in human cancer
por: Liu, Xin, et al.
Publicado: (2022)

Oncogenic Role of Guanylate Binding Protein 1 in Human Prostate Cancer
por: Zhao, Jing, et al.
Publicado: (2020)

A Pan-Cancer Analysis of the Oncogenic Role of BCL7B: A Potential Biomarker for Prognosis and Immunotherapy
por: Yang, Dinglong, et al.
Publicado: (2022)

Pan-cancer analysis of ADAMs: A promising biomarker for prognosis and response to chemotherapy and immunotherapy
por: Ma, Bo, et al.
Publicado: (2023)

Comprehensive pan-cancer analysis of N7-methylguanosine regulators: Expression features and potential implications in prognosis and immunotherapy
por: Wei, Wei, et al.
Publicado: (2022)

Leptin Receptor Overlapping Transcript (LEPROT) Is Associated with the Tumor Microenvironment and a Prognostic Predictor in Pan-Cancer
por: Li, Bingsheng, et al.
Publicado: (2021)

Cell death-related biomarker SLC2A1 has a significant role in prognosis prediction and immunotherapy efficacy evaluation in pan-cancer
por: Wang, Yuhang, et al.
Publicado: (2023)

When human guanylate-binding proteins meet viral infections
por: Zhang, Rongzhao, et al.
Publicado: (2021)

PanSVR: Pan-Genome Augmented Short Read Realignment for Sensitive Detection of Structural Variations
por: Li, Gaoyang, et al.
Publicado: (2021)

Pan-cancer analysis of the prognostic and immunological role of ANLN: An onco-immunological biomarker
por: Liu, Kejun, et al.
Publicado: (2022)

Comprehensive Pan-Cancer Analysis of Senescence With Cancer Prognosis and Immunotherapy
por: Zhao, Qinfei, et al.
Publicado: (2022)

Pan-glioma analyses reveal species- and tumor-specific regulation of neuron-glioma synapse genes by lncRNAs
por: Xiong, Wei, et al.
Publicado: (2023)

A pan-cancer analysis of the prognostic value of long non-coding RNA LINC00662 in human cancers
por: Zhang, Guangming, et al.
Publicado: (2022)

Integrative modeling of guanylate binding protein dimers
por: Schumann, Wibke, et al.
Publicado: (2023)

X-box Binding Protein 1 is a Potential Immunotherapy Target in Ovarian Cancer
por: Jiang, Yanhui, et al.
Publicado: (2022)

Prognostic and immunological role of SERPINH1 in pan-cancer
por: Zhong, Huage, et al.
Publicado: (2022)

Potentiality of forkhead box Q1 as a biomarker for monitoring tumor features and predicting prognosis in non‐small cell lung cancer
por: Li, Lan, et al.
Publicado: (2019)

Systematic pan-cancer analysis of the nicotinamide n-methyltransferase in human cancer
por: Cao, Li, et al.
Publicado: (2022)

Guanylate‐binding proteins signature predicts favorable prognosis, immune‐hot microenvironment, and immunotherapy response in hepatocellular carcinoma
por: Ning, Yumei, et al.
Publicado: (2023)

RNA-Binding Protein IGF2BP1 Associated With Prognosis and Immunotherapy Response in Lung Adenocarcinoma
por: Liu, JinFeng, et al.
Publicado: (2022)

Guanylate binding protein-1 mediates EGFRvIII and promotes glioblastoma growth in vivo but not in vitro
por: Lan, Qing, et al.
Publicado: (2016)

The Wnt/β-Catenin/LEF1 Pathway Promotes Cell Proliferation at Least in Part Through Direct Upregulation of miR-17-92 Cluster
por: Mu, Fang, et al.
Publicado: (2019)

A Pan-Cancer In Silico Analysis of the COVID-19 Internalization Protease: Transmembrane Proteaseserine-2
por: Meng, Yiming, et al.
Publicado: (2022)

Pan-Cancer Analysis of PIMREG as a Biomarker for the Prognostic and Immunological Role
por: Zhu, Hua, et al.
Publicado: (2021)

Ferroptosis-Related Gene Signature Predicts the Prognosis of Skin Cutaneous Melanoma and Response to Immunotherapy
por: Xu, Ziqian, et al.
Publicado: (2021)

Pan-Cancer Bioinformatics Analysis of Gene UBE2C
por: Yuan, Lin, et al.
Publicado: (2022)

Pan-Cancer Analysis of OLFML2B Expression and Its Association With Prognosis and Immune Infiltration
por: Hu, Pengbo, et al.
Publicado: (2022)

Biomarker Categorization in Transcriptomic Meta-Analysis by Concordant Patterns With Application to Pan-Cancer Studies
por: Ye, Zhenyao, et al.
Publicado: (2021)

Pan-cancer analyses reveal IGSF10 as an immunological and prognostic biomarker
por: Zhou, Yongxia, et al.
Publicado: (2023)

A systematic pan-cancer analysis reveals the clinical prognosis and immunotherapy value of C-X3-C motif ligand 1 (CX3CL1)
por: Sun, Yidi
Publicado: (2023)

Subtyping of microsatellite stability colorectal cancer reveals guanylate binding protein 2 (GBP2) as a potential immunotherapeutic target
por: Wang, Haizhou, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9df91rfaicv3sudj0nt4rgadiq